Good Life Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Sell |
20,433
-108
| -0.5% | -$16.6K | 0.2% | 96 |
|
|
2025
Q1 | $3.41M | Sell |
20,541
-1,218
| -6% | -$191K | 0.24% | 89 |
|
|
2024
Q4 | $3.15M | Sell |
21,759
-2,211
| -9% | -$343K | 0.23% | 91 |
|
|
2024
Q3 | $3.88M | Buy |
23,970
+2,981
| +14% | +$475K | 0.24% | 86 |
|
|
2024
Q2 | $3.07M | Sell |
20,989
-535
| -2% | -$79.6K | 0.25% | 81 |
|
|
2024
Q1 | $3.4M | Sell |
21,524
-757
| -3% | -$120K | 0.3% | 70 |
|
|
2023
Q4 | $3.49M | Sell |
22,281
-675
| -3% | -$104K | 0.35% | 57 |
|
|
2023
Q3 | $3.58M | Sell |
22,956
-344
| -1% | -$56.8K | 0.41% | 54 |
|
|
2023
Q2 | $3.86M | Buy |
23,300
+2,310
| +11% | +$373K | 0.43% | 48 |
|
|
2023
Q1 | $3.25M | Sell |
20,990
-1,425
| -6% | -$230K | 0.42% | 56 |
|
|
2022
Q4 | $3.96M | Sell |
22,415
-654
| -3% | -$113K | 0.55% | 45 |
|
|
2022
Q3 | $3.77M | Buy |
23,069
+810
| +4% | +$137K | 0.56% | 49 |
|
|
2022
Q2 | $3.95M | Buy |
22,259
+1,075
| +5% | +$192K | 0.55% | 47 |
|
|
2022
Q1 | $3.75M | Buy |
21,184
+603
| +3% | +$103K | 0.47% | 49 |
|
|
2021
Q4 | $3.52M | Buy |
20,581
+881
| +4% | +$144K | 0.43% | 53 |
|
|
2021
Q3 | $3.18M | Buy |
19,700
+4,225
| +27% | +$721K | 0.43% | 52 |
|
|
2021
Q2 | $2.55M | Sell |
15,475
-110
| -0.7% | -$18.2K | 0.48% | 44 |
|
|
2021
Q1 | $2.56M | Sell |
15,585
-533
| -3% | -$86.2K | 0.52% | 42 |
|
|
2020
Q4 | $2.54M | Buy |
16,118
+900
| +6% | +$133K | 0.59% | 35 |
|
|
2020
Q3 | $2.27M | Sell |
15,218
-1,634
| -10% | -$242K | 0.62% | 36 |
|
|
2020
Q2 | $2.38M | Buy |
16,852
+129
| +0.8% | +$18.8K | 0.71% | 33 |
|
|
2020
Q1 | $2.19M | Buy |
16,723
+554
| +3% | +$78.6K | 0.79% | 28 |
|
|
2019
Q4 | $2.36M | Buy |
16,169
+367
| +2% | +$49.8K | 0.67% | 28 |
|
|
2019
Q3 | $2.04M | Buy |
15,802
+465
| +3% | +$61.3K | 0.63% | 33 |
|
|
2019
Q2 | $2.14M | Sell |
15,337
-306
| -2% | -$42.4K | 0.61% | 29 |
|
|
2019
Q1 | $2.19M | Sell |
15,643
-957
| -6% | -$128K | 0.65% | 27 |
|
|
2018
Q4 | $2.14M | Buy |
16,600
+1,378
| +9% | +$192K | 0.69% | 31 |
|
|
2018
Q3 | $2.1M | Buy |
15,222
+417
| +3% | +$55.4K | 0.61% | 36 |
|
|
2018
Q2 | $1.79M | Sell |
14,805
-1,380
| -9% | -$172K | 0.57% | 35 |
|
|
2018
Q1 | $2M | Buy |
16,185
+181
| +1% | +$24.5K | 0.68% | 31 |
|
|
2017
Q4 | $2.28M | Buy |
16,004
+38
| +0.2% | +$5.29K | 0.71% | 32 |
|
|
2017
Q3 | $2.13M | Sell |
15,966
-742
| -4% | -$98.4K | 0.8% | 27 |
|
|
2017
Q2 | $2.2M | Sell |
16,708
-1,271
| -7% | -$162K | 0.96% | 24 |
|
|
2017
Q1 | $2.23M | Buy |
17,979
+1,176
| +7% | +$140K | 1.06% | 22 |
|
|
2016
Q4 | $1.93M | Buy |
+16,803
| New | +$1.94M | 1.12% | 18 |
|
Other funds holding JNJ
Good Life Advisors's JNJ Position: Q2 2025 in Review
Good Life Advisors reduced its Johnson & Johnson (JNJ) stake by 0.53% in Q2 2025, selling an estimated $16.6K and leaving 20,433 shares worth $3.12M. The position accounts for 0.2% of the portfolio, ranked #96.
Good Life Advisors first reported a position in JNJ in Q4 2016 and has held it in 35 quarters since. The position peaked at $3.96M in Q4 2022. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Good Life Advisors held 20,433 shares of Johnson & Johnson worth $3.12M as of Q2 2025.
- Good Life Advisors sold 108 Johnson & Johnson shares in Q2 2025, an estimated $16.6K.
- Johnson & Johnson made up 0.2% of Good Life Advisors's portfolio in Q2 2025, its #96 holding.
- Good Life Advisors first reported a position in Johnson & Johnson in Q4 2016 and has held it in 35 quarters since.
- Good Life Advisors's Johnson & Johnson position peaked at $3.96M in Q4 2022.
- 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.